HLB bioStep Co.,Ltd.
278650 | KO
Overview
Corporate Details
- ISIN(s):
- KR7278650007
- LEI:
- Country:
- South Korea
- Address:
- 인천광역시 연수구 아카데미로79번길 38 -, 인천광역시
- Website:
- http://hlbbiostep.com/en/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-20 00:00 |
Share Issue/Capital Change
전환가액의조정
|
Korean | 12.1 KB | ||
| 2025-08-20 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 103.7 KB | ||
| 2025-08-14 00:00 |
Interim / Quarterly Report
[기재정정]반기보고서 (2025.06)
|
Korean | 1.4 MB | ||
| 2025-08-13 00:00 |
Interim / Quarterly Report
반기보고서 (2025.06)
|
Korean | 1.4 MB | ||
| 2025-06-30 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB | ||
| 2025-06-30 00:00 |
Regulatory Filings
[기재정정]신규시설투자등
|
Korean | 10.7 KB | ||
| 2025-05-27 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 104.4 KB | ||
| 2025-05-22 00:00 |
Transaction in Own Shares
신탁계약해지결과보고서
|
Korean | 19.5 KB | ||
| 2025-05-20 00:00 |
Share Issue/Capital Change
전환가액의조정
|
Korean | 11.8 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.1 MB | ||
| 2025-04-30 00:00 |
Regulatory Filings
소속부변경
|
Korean | 3.6 KB | ||
| 2025-03-26 00:00 |
AGM Information
정기주주총회결과
|
Korean | 30.4 KB | ||
| 2025-03-26 00:00 |
Board/Management Information
대표이사변경
|
Korean | 10.2 KB | ||
| 2025-03-26 00:00 |
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 14.8 KB | ||
| 2025-03-18 00:00 |
Audit Report / Information
감사보고서제출
|
Korean | 25.7 KB |
Automate Your Workflow. Get a real-time feed of all HLB bioStep Co.,Ltd. filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for HLB bioStep Co.,Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for HLB bioStep Co.,Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Developing innovative ophthalmology drugs for glaucoma and ocular hypertension.
France
COX
France
COX
Developing therapies for rare CNS disorders, specializing in narcolepsy and sleep-wake issues.
United States of America
NLSP
United States of America
NLSP
Develops a non-invasive electric field therapy to disrupt and treat aggressive solid tumor cancers.
United States of America
NVCR
United States of America
NVCR
Repurposing drugs for fibrosis and oncology using proprietary cocrystal technology.
United Kingdom
NFX
United Kingdom
NFX
Developing protein degradation medicines to treat cancer and autoimmune diseases.
United States of America
NRIX
United States of America
NRIX
Biotech firm developing RNA therapeutics for diseases with its proprietary OPNA platform.
South Korea
244460
South Korea
244460
United States of America
OABIW
Antibody biomarker discovery platform for pharma and biotech partners in oncology and autoimmune disease.
United Kingdom
ONC
United Kingdom
ONC
AI-powered biotech accelerating drug development for cancer and rare diseases.
South Korea
382150
South Korea
382150
Developing precision oncology solutions for resistant and metastatic cancers.
France
ALONC
France
ALONC